Oppenheimer 35th Annual Healthcare Life Sciences Conference Presentation Date: Tuesday, February 11, 2025 at 2:40 PM ET Presentation Format: Corporate Presentation Webcast: ...
As CTO, Mr. Beneski will oversee Allogene’s technical operations, leveraging his extensive expertise in biologics manufacturing, process development, and operational leadership to carry on the work of ...
Check the time stamp on this data. Updated AI-Generated Signals for Soleno Therapeutics Inc. (SLNO) available here: SLNO.
In trading on Wednesday, shares of Soleno Therapeutics Inc (Symbol: SLNO) crossed above their 200 day moving average of $47.25, changing hands as high as $48.43 per share. Soleno Therapeutics Inc ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Fraser Murray, PhD, CEO, Pheno Therapeutics. Image Credit: Pheno Therapeutics A selective GPR17 (G protein-coupled receptor 17) antagonist, PTD802 is a novel small molecule therapeutic designed to ...
EMERYVILLE, Calif., Jan. 13, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna, NASDAQ: KYTX), a clinical-stage biopharmaceutical company focused on developing ...
In this article, we are going to take a look at where Soleno Therapeutics, Inc. (NASDAQ:SLNO) stands against other top small cap stocks to buy with the highest upside potential. On December 30 ...
EMERYVILLE, Calif., Jan. 13, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna, NASDAQ: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with ...
Soleno Therapeutics, Inc. has a one year low of $36.61 and a one year high of $60.92. The stock’s 50 day moving average price is $50.16 and its 200 day moving average price is $49.41.